Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial

Annals of Oncology

Volumn 9, Issue 5, 1998, Pages 565-567

  Campisi, C ^a   Fabi, A ^b   Papaldo, P ^b   Tomao, S ^c   Massidda, B ^d   Zappala, A ^e   Ionta, M T ^d   Cognetti, F ^b  

^a CNR   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ifosfamide; Metastatic breast cancer; Vinorelbine

Indexed keywords

IFOSFAMIDE; NAVELBINE;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS POTENTIAL; NAUSEA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0031864322     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008221109364     Document Type: Article

References (11)

1. Boddy AV, Proctor M, Simmonds D et al. Pharmacokinetic metabolism and clinical effect of ifosfamide in breast cancer patients. Eur J Cancer 1995; 31A(I): 69 76.
2. Brock N, Pohl J, Stekar J. Studies on the urotoxicity of oxazaphosphorine, cytostatics and its prevention-III: Profile of action of sodium 2-mercaptoethane sulfonate (MESNA). Eur K Cancer Clin Oncol 1982; 18: 1377-87.
3. Dechant KL, Brogden RN, Philkington T et al. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 1991; 42 (3): 428 67.
4. Gad-El Mawla N. Use of ifosfamide in the management of breast cancer. Ann Oncol 1992; 3 (Suppl 3): 21 3.
5. Marty M, Mignol L, Calvo F et al. Traitement du cancer de sein. Encyclopedic Medico-Chirurgicale (Paris) 1989; 870(10): 201 13.
6. Hortobagy GN. Activity of ifosfamide in breast cancer. Semin Oncol 1992; 19 (Suppl 12): 36-41.
7. Sanchiz F, Milla A. High-dose ifosfamide and mesna in advanced breast cancer. Cancer Chemother Pharmacol 1990; 26 (Suppl): S91 2.
8. Kerbrat P, Delgado FM, Fumoleau P et al. Phase II trial with Vinorelbine (navelbine) in advanced breast cancer. Proceedings of the 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy. Amsterdam 1992; 126.
9. Leone BA, Vallejo CT, Romero AO et al. Ifosfamide and Vinorelbine as first-line chemotherapy for metastatic breast cancer. J Clin Oncol 1996; 14 (11): 2993-9.
10. Allen LM, Creaven PJ, Nelson RL. Studies on human pharmacokinetics of isophosphamide. Cancer Treat Rep 1976; 60: 451 8.
11. Bruno M. Second-line therapy with ifofamide plus vinorelbine (VRB) for advanced breast cancer. A phase I II GETLAC study. Proc Am Soc Clin Oncol 1997; 570.